Tigecycline Injection
|
Generic Name |
Tigecycline |
|---|---|
|
Strength |
50 mg |
|
Form |
Injection |
|
Packaging |
Vial |
|
Therapeutic use |
Antibiotic, Pneumonia |
|
Manufacturing Period |
30 to 45 Days |
Available Composition of
| Name | Strength | Therapeutic use | View More |
|---|---|---|---|
| Tigecycline Injection | 50 mg | Antibiotic, Pneumonia |
Product Description For Tigecycline Injection
products details and uses
Tigecycline Injection Exporter, Manufacturer and Global Supplier
Tigecycline Injection Exporter, as a trusted we deliver this life-saving formulation that meets global pharmaceutical standards and ensures safety, efficacy, and reliability for healthcare professionals worldwide. Tigecycline belongs to the glycylcycline class of antibiotics and works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and spread. Tigecycline Injection is a broad-spectrum antibiotic widely used to treat complicated bacterial infections resistant to other antibiotics.
This injection is primarily used in hospital settings for the treatment of severe infections caused by multidrug-resistant organisms. Our role as a reputable Tigecycline Injection Exporter ensures that we supply high-quality formulations suitable for global healthcare markets. Manufactured under WHO-GMP and ISO-certified facilities, each batch of Tigecycline Injection is carefully tested for potency, purity, and stability before export.
Uses of Tigecycline Injection
Tigecycline Injection is prescribed for the treatment of various severe bacterial infections, including complicated intra-abdominal infections, complicated skin and soft tissue infections, and community-acquired bacterial pneumonia. It is particularly effective against antibiotic-resistant bacteria, including strains that no longer respond to penicillins, cephalosporins, or fluoroquinolones.
As a globally recognized Tigecycline Injection Exporter, we ensure that our product is formulated to meet the clinical needs of healthcare institutions across different regions. It is especially valuable in intensive care units where infections caused by multidrug-resistant pathogens pose a major therapeutic challenge. Tigecycline offers a dependable solution for physicians handling critical infection management.
Precautions Before Using Tigecycline Injection
Before administering Tigecycline Injection, healthcare professionals should review the patient’s medical history, including any history of allergies to tetracycline-class antibiotics. Since this medicine may cause photosensitivity, patients should avoid prolonged exposure to sunlight or UV lamps during treatment.
As a responsible Tigecycline Injection Exporter, we emphasize adherence to safety protocols and accurate dosage recommendations. Tigecycline should only be administered intravenously under medical supervision. It is not recommended for use in children under eight years old due to the risk of tooth discoloration and effects on bone growth.
Pregnant and breastfeeding women should use Tigecycline only if clearly needed and prescribed by a healthcare provider, as it may affect fetal bone and teeth development. Patients with liver impairment should receive adjusted doses, and continuous monitoring of liver enzymes is advised during prolonged therapy.
It is crucial to complete the full prescribed course of Tigecycline Injection to prevent recurrence of infection or antibiotic resistance. Using it unnecessarily or skipping doses can reduce its effectiveness and increase bacterial resistance.
Side Effects of Tigecycline Injection
While Tigecycline Injection is highly effective, some patients may experience mild to moderate side effects. Common side effects include nausea, vomiting, diarrhea, headache, and injection site irritation. In rare cases, it may cause severe allergic reactions, jaundice, or liver dysfunction.
As an ethical Tigecycline Injection Exporter, we ensure all packaging includes clear information on potential side effects and medical precautions. If a patient experiences persistent vomiting, severe abdominal pain, yellowing of the eyes or skin, or any signs of allergic reaction such as rash or swelling, immediate medical attention should be sought.
Healthcare professionals are encouraged to monitor patient responses during treatment and adjust the dosage as necessary. Because Tigecycline can alter gut flora, cases of antibiotic-associated colitis have been reported—prompt discontinuation is recommended if such symptoms occur.
Why Choose Us as Your Tigecycline Injection Exporter
As a leading Tigecycline Injection Exporter, we are committed to providing premium-quality antibiotics that meet stringent international standards. Our manufacturing facilities are certified under WHO-GMP guidelines, ensuring top-notch formulation quality and safety. We maintain a robust global supply chain, allowing us to deliver Tigecycline Injection promptly and efficiently to hospitals, wholesalers, and government institutions across Asia, Africa, Europe, and Latin America.
We provide Tigecycline Injection in various packaging sizes and strengths to meet specific client needs. Our expertise as a trusted Tigecycline Injection Exporter extends beyond product supply—we also offer customized export documentation support, regulatory assistance, and private labeling services for international partners.
In summary, Tigecycline Injection stands as a dependable treatment option against complicated bacterial infections, offering exceptional efficacy against resistant pathogens. Supported by global quality standards, our company has established itself as a top-tier Tigecycline Injection Exporter, dedicated to enhancing patient care and supporting healthcare systems worldwide with reliable, affordable, and high-quality antibiotic solutions.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export Loxapine Capsule to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.
